Recurrent Renal Cell Cancer Clinical Trials

51 clinical trials for Recurrent Renal Cell Cancer across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• CAIX PET/ CT Guided Radiation Therapy in CcRCC. — RECRUITING · NA
• SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer — RECRUITING
• Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC) — RECRUITING
• Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer — COMPLETED · PHASE2
• flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer — COMPLETED · PHASE2
• Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma — COMPLETED · PHASE1
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene — COMPLETED · PHASE1
• Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate — TERMINATED · PHASE1
• Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery — COMPLETED · NA
• Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer — COMPLETED · PHASE2
• CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer — COMPLETED · PHASE1
• Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer — COMPLETED · PHASE1
• Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer — TERMINATED · PHASE1
• Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers — COMPLETED · NA
• Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer — COMPLETED · PHASE1
• Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant — COMPLETED · PHASE1
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy — COMPLETED · PHASE1
• Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer — COMPLETED · PHASE1
• Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer — TERMINATED · NA
• Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer — TERMINATED · PHASE2
• APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery — COMPLETED · PHASE1
• Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer — COMPLETED · PHASE2
• Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors — COMPLETED · PHASE1
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer — TERMINATED · NA
• Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer — TERMINATED · PHASE1
• Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer — TERMINATED · PHASE2
• Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors — COMPLETED · PHASE1
• Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer — COMPLETED · PHASE1
• Clamped or Unclamped Surgery in Treating Patients With Kidney Cancer — TERMINATED · NA
• Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer — TERMINATED · PHASE2
• Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer — TERMINATED · PHASE1
• Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies — COMPLETED · PHASE1
• Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy — COMPLETED · PHASE1
• AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery — COMPLETED · PHASE1
• Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer — COMPLETED · PHASE2
• BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer — WITHDRAWN · PHASE2
• Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer — TERMINATED · PHASE2
• Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment — COMPLETED · PHASE2
• Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer — COMPLETED · PHASE2
• Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery — COMPLETED · PHASE1
• Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors — COMPLETED · PHASE1
• Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors — COMPLETED · PHASE1
• Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer — COMPLETED · PHASE2
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu — COMPLETED · PHASE1
• Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer — COMPLETED · PHASE2
• Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer — COMPLETED · PHASE2
• Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer — COMPLETED · PHASE2
• SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment — TERMINATED · PHASE2

Refine this search